1419.8000 -19.10 (-1.33%)
NSE Aug 12, 2025 13:03 PM
Volume: 12,844
 

1419.80
-1.33%
Prabhudas Lilladhar
JLHL's Q1 consolidated EBITDA grew by 20% YoY (flat QoQ) to Rs781mn, in line with our estimates, aided by higher ARPOB. Its operational efficiency has been strong in the competitive markets of MMR. The company reported revenue/EBITDA CAGR of 20%/25% over FY22-25. Given its expansion plans, scale-up in occupancy and improving margins, growth momentum is expected to sustain over the medium term. We believe strategic greenfield expansions in densely populated micro-markets of western regions will drive sustainable...
Prabhudas Lilladhar released a Buy report for Jupiter Life Line Hospitals Ltd. with a price target of 1720.0 on 05 Aug, 2025.
More from Jupiter Life Line Hospitals Ltd.
Recommended